FORM OF LOCK-UP AGREEMENTBain Capital Life Sciences Fund, L.P. • July 3rd, 2018 • Pharmaceutical preparations • New York
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GBain Capital Life Sciences Fund, L.P. • February 13th, 2024 • Pharmaceutical preparations
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GBain Capital Life Sciences Fund, L.P. • February 13th, 2024 • Biological products, (no disgnostic substances)
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GBain Capital Life Sciences Fund, L.P. • June 23rd, 2023 • Pharmaceutical preparations
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GBain Capital Life Sciences Fund, L.P. • February 14th, 2023 • Biological products, (no disgnostic substances)
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DBain Capital Life Sciences Fund, L.P. • July 3rd, 2018 • Pharmaceutical preparations
The undersigned being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, as amended, to file this Schedule (including amendments thereto) jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GBain Capital Life Sciences Fund, L.P. • May 30th, 2023 • Pharmaceutical preparations
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GBain Capital Life Sciences Fund, L.P. • January 22nd, 2024 • Pharmaceutical preparations
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DBain Capital Life Sciences Fund, L.P. • February 7th, 2020 • Pharmaceutical preparations
The undersigned being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, as amended, to file this Schedule 13D (including amendments thereto) jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DBain Capital Life Sciences Fund, L.P. • August 22nd, 2019 • Pharmaceutical preparations
The undersigned being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, as amended, to file this Schedule 13D (including amendments thereto) jointly on behalf of each such party.
REGISTRATION RIGHTS AGREEMENT BY AND AMONG DYNAVAX TECHNOLOGIES CORPORATION AND CERTAIN STOCKHOLDERS DATED AS OF MARCH 11, 2020Registration Rights Agreement • March 12th, 2020 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of March 11, 2020, is made by and among:
Bain Capital Life Sciences Fund, L.P. BCIP Life Sciences Associates, LP 200 Clarendon Street Boston, MA 02116Registration Rights Agreement • March 12th, 2020 • Bain Capital Life Sciences Fund, L.P. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of , 2020, is made by and among:
